Barclays’s AMN Healthcare AMN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-4,100
Closed -$340K 4532
2023
Q1
$340K Buy
+4,100
New +$386K ﹤0.01% 3515
2019
Q1
Sell
-100,000
Closed -$5.67M 6982
2018
Q4
$5.67M Sell
100,000
-326,100
-77% -$18.3M ﹤0.01% 1515
2018
Q3
$23.3M Buy
+426,100
New +$24.4M 0.02% 767

Other funds holding AMN

Barclays's AMN Position: Q1 2026 in Review

Barclays reduced its AMN Healthcare (AMN) stake by 88% in Q1 2026, selling an estimated $1.01M and leaving 7,342 shares worth $135K. The position accounts for ﹤0.01% of the portfolio, ranked #3904.

Barclays first reported a position in AMN in Q2 2013 and has held it in 52 quarters since. The position peaked at $13.3M in Q2 2025. 249 funds tracked by Wall St. Rank hold AMN as of Q1 2026.

  • Barclays held 7,342 shares of AMN Healthcare worth $135K as of Q1 2026.
  • Barclays sold 53,053 AMN Healthcare shares in Q1 2026, an estimated $1.01M.
  • AMN Healthcare made up ﹤0.01% of Barclays's portfolio in Q1 2026, its #3904 holding.
  • Barclays first reported a position in AMN Healthcare in Q2 2013 and has held it in 52 quarters since.
  • Barclays's AMN Healthcare position peaked at $13.3M in Q2 2025.
  • 249 funds tracked by Wall St. Rank held AMN Healthcare as of Q1 2026.

Based on Barclays's 13F filing for Q1 2026, filed 15 May 2026.